InvestorsHub Logo
Followers 39
Posts 3916
Boards Moderated 0
Alias Born 08/15/2009

Re: nycusa12 post# 85

Wednesday, 05/10/2017 12:34:58 PM

Wednesday, May 10, 2017 12:34:58 PM

Post# of 289
I am an old MSTX bag holder and hard to determine present value, some here have shared anywhere from 50-250 million.

Sure analyst will come out with high low the next couple weeks. Yahoo has target at $185 share price which is far fetched.

Know value more than 50 mill because MSTX had over 10 million in cash with a heart drug valued at over 100 million.

I do know with 3 drugs in pipe and value if successful it will be far more than 250 million.

My focus for not selling at merger was present CEO. Proven track record and knows how to make money with 3 drugs in pipeline, all looking good.

Remember this has a low float, and any elevation in price will send it off the charts. I believe in next month that will be the case. Added 100 extra shares each time it hits below $5.70. Done it three times.

Also remember in PR Monday "the approval of the product in the U.S. by eliminating the need to conduct a separate Phase 3 study," stated Rob Neville, " ..... If this is the case watch out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SVRA News